A new MS drug Copaxone shows promise in reducing heart attack risk, offering potential benefits beyond multiple sclerosis for heart health and...
Vous n'êtes pas connecté
PIPE-307, a new drug targeting the M1R receptor, shows promise in halting and potentially reversing nerve damage in Multiple sclerosis by regenerating the myelin sheath.
A new MS drug Copaxone shows promise in reducing heart attack risk, offering potential benefits beyond multiple sclerosis for heart health and...
The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...
The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...
A new research paper was published in Oncotarget's Volume 15 on August 26, 2024, entitled, "Inhibition of miR-10b treats metastatic breast cancer by...
WashU Medicine researchers have designed, in mice, an approach to minimizing the damage from a spinal cord injury through the use of engineered immune...
WashU Medicine researchers have designed, in mice, an approach to minimizing the damage from a spinal cord injury through the use of engineered immune...
Alzheimer’s, Parkinson’s, and other neurological diseases can be thought of as “dirty brain” conditions, where the brain struggles to clear...
Neuromodulation offers a minimally invasive, reversible treatment for overactive bladder (OAB), targeting nerve activity to improve symptoms and...
Neuromodulation offers a minimally invasive, reversible treatment for overactive bladder (OAB), targeting nerve activity to improve symptoms and...